HSL Mobile App 
52 week Low
636.10
636.10
52 week High
808.80
808.80
721.50
Day low
716.60
716.60
Day high
734.80
734.80
721.50
Prev Close
731.75
731.75
Open
727.60
727.60
6M return
-5.64%
-5.64%
1Y return
-5.64%
-5.64%
MCap(Rs. in Cr.)
16,069.79
16,069.79
Total Volume
4,91,030
4,91,030
Face Value : 1
Listed Since 18 Dec 2024
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
116.16314
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
6.62
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
7.53
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
24.01%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.00
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
752.47
752.47
Resistance 2
773.18
773.18
Support 1
718.02
718.02
Support 2
704.28
704.28
Moving Average
20 Days
722.07
722.07
50 Days
707.09
707.09
100 Days
711.39
711.39
200 Days
711.39
711.39
Growth in 3 years
Sales
68.49%
Sales Industry Avg
31.22%
PAT
1,229.21%
PAT Industry Avg
27.90%
68.49%
Sales Industry Avg
31.22%
PAT
1,229.21%
PAT Industry Avg
27.90%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 439.78 | 395.56 | 279.72 | 439.21 | 1,465.18 |
| Gross Profit | 105.74 | 91.24 | 13.01 | 107.11 | 228.67 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 63.76 | 50.12 | -22.10 | 61.06 | 109.24 |
| Tax | 9.91 | 8.61 | -8.60 | 4.93 | 26.43 |
| Profit After Tax | 53.85 | 41.51 | -13.50 | 56.13 | 82.81 |
Growth in 3 years
Total Asset Growth
5.96%
Total Liabilities growth
16.74%
Reserves Change
11.21%
5.96%
Total Liabilities growth
16.74%
Reserves Change
11.21%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2019 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 18.05 | 18.01 | 17.94 | 17.82 | 16.37 |
| Reserves And Surplus | 957.09 | 870.08 | 860.62 | 845.13 | 703.17 |
| Investments | 1.87 | 1.87 | 0.02 | 0.02 | 0.02 |
| Total Debt | 927.66 | 932.38 | 751.32 | 636.70 | 249.05 |
| Total Liabilities | 1,902.80 | 1,820.47 | 1,629.88 | 1,499.65 | 968.59 |
| Total Assets | 1,895.39 | 1,816.02 | 1,788.78 | 1,481.19 | 983.90 |
No data available
Relative to Sensex rtn in 3 year
-115.08%
Relative to Nifty rtn in 3 year
-114.51%
Relative to top 3 MF rtn in 3 year
-115.08%
Relative to Nifty rtn in 3 year
-114.51%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Sai Life | -6 | -6 | -6 |
| Bse Sensex | 8 | 31 | 37 |
| Nifty 50 | 8 | 35 | 39 |
| Nifty 500 | 6 | 45 | 45 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Sai Life
721.50 chg : -10.25 (-1.40%)
721.50 chg : -10.25 (-1.40%)
Emcure Pharma
1098.80 chg : 1098.80 (0.00%)
1098.80 chg : 1098.80 (0.00%)
Blue Jet Health
762.20 chg : 14.85 (1.99%)
762.20 chg : 14.85 (1.99%)
Sanofi Consumer
4938.20 chg : -47.60 (-0.95%)
4938.20 chg : -47.60 (-0.95%)
Akums Drugs
486.35 chg : -12.80 (-2.56%)
486.35 chg : -12.80 (-2.56%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 94,356.90 with a Loss of -5.64%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
No data available
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
No data available
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
| No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Sai Life Sciences inaugurates Peptide Research Center in Hyderabad
Sai Life Sciences has inaugurated a dedicated Peptide Research Center at its integrated R&D Campus in Hyderabad, India.The Peptide....
04 Apr 2025 13:58Sai Life Sciences consolidated net profit rises 35.95% in the December 2024 quarter
Net profit of Sai Life Sciences rose 35.95% to Rs 53.85 crore in the quarter ended December 2024 as against Rs 39.61 crore during the previous quarter....
07 Feb 2025 07:34Sai Life Sciences schedules board meeting
Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live News<....
24 Jan 2025 13:43Shares of Sai Life Sciences lists today
The equity shares of Sai Life Sciences (Scrip Code: 544306) are listed effective 18 December 2024 and admitted to dealings on the Exchange in the list....
18 Dec 2024 09:25__heading__
Published on __date__ at __time__
__description__
